BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Schafer CC, Hough KP, Tousif S, Duncan SR, Kearney JF, Ponnazhagan S, Hsu HC, Deshane JS. Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol. 2018;201:278-295. [PMID: 29752311 DOI: 10.4049/jimmunol.1701069] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
Number Citing Articles
1 Tavukcuoglu E, Horzum U, Yanik H, Uner A, Yoyen-Ermis D, Nural SK, Aydin B, Sokmensuer C, Karakoc D, Yilmaz KB, Hamaloglu E, Esendagli G. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer. Eur J Immunol 2020;50:2067-74. [PMID: 32691408 DOI: 10.1002/eji.202048666] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
2 Koomullil R, Tehrani B, Goliwas K, Wang Y, Ponnazhagan S, Berry J, Deshane J. Computational Simulation of Exosome Transport in Tumor Microenvironment. Front Med (Lausanne) 2021;8:643793. [PMID: 33928104 DOI: 10.3389/fmed.2021.643793] [Reference Citation Analysis]
3 Pritchard A, Tousif S, Wang Y, Hough K, Khan S, Strenkowski J, Chacko BK, Darley-Usmar VM, Deshane JS. Lung Tumor Cell-Derived Exosomes Promote M2 Macrophage Polarization. Cells 2020;9:E1303. [PMID: 32456301 DOI: 10.3390/cells9051303] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 24.0] [Reference Citation Analysis]
4 Liu M, Wei F, Wang J, Yu W, Shen M, Liu T, Zhang D, Wang Y, Ren X, Sun Q. Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1-PD-L1+ Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer. Cell Death Dis 2021;12:465. [PMID: 33967272 DOI: 10.1038/s41419-021-03745-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2020;26:2645-56. [PMID: 32523317 DOI: 10.3748/wjg.v26.i20.2645] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shi H, Li K, Ni Y, Liang X, Zhao X. Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy. Front Cell Dev Biol 2021;9:707198. [PMID: 34336860 DOI: 10.3389/fcell.2021.707198] [Reference Citation Analysis]
7 Polak KL, Chernosky NM, Smigiel JM, Tamagno I, Jackson MW. Balancing STAT Activity as a Therapeutic Strategy. Cancers (Basel) 2019;11:E1716. [PMID: 31684144 DOI: 10.3390/cancers11111716] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Yin K, Xia X, Rui K, Wang T, Wang S. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression. Front Oncol 2020;10:610104. [PMID: 33384962 DOI: 10.3389/fonc.2020.610104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Najafi M, Goradel NH, Farhood B, Salehi E, Solhjoo S, Toolee H, Kharazinejad E, Mortezaee K. Tumor microenvironment: Interactions and therapy. J Cell Physiol. 2019;234:5700-5721. [PMID: 30378106 DOI: 10.1002/jcp.27425] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 23.7] [Reference Citation Analysis]
10 Mandula JK, Rodriguez PC. Tumor-related stress regulates functional plasticity of MDSCs. Cell Immunol 2021;363:104312. [PMID: 33652258 DOI: 10.1016/j.cellimm.2021.104312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cheng A, Vantucci CE, Krishnan L, Ruehle MA, Kotanchek T, Wood LB, Roy K, Guldberg RE. Early systemic immune biomarkers predict bone regeneration after trauma. Proc Natl Acad Sci U S A 2021;118:e2017889118. [PMID: 33597299 DOI: 10.1073/pnas.2017889118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Xu Y, Fang F, Jiao H, Zheng X, Huang L, Yi X, Zhao W. Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma. Cancer Immunol Immunother 2019;68:1959-69. [PMID: 31641797 DOI: 10.1007/s00262-019-02414-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
13 Sharma V, Aggarwal A, Jacob J, Sahni D. Myeloid-derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma. Scand J Immunol 2021;93:e13021. [PMID: 33455004 DOI: 10.1111/sji.13021] [Reference Citation Analysis]
14 Largeot A, Pagano G, Gonder S, Moussay E, Paggetti J. The B-side of Cancer Immunity: The Underrated Tune. Cells 2019;8:E449. [PMID: 31086070 DOI: 10.3390/cells8050449] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 20.5] [Reference Citation Analysis]
15 Sivagnanalingam U, Beatty PL, Finn OJ. Myeloid derived suppressor cells in cancer, premalignancy and inflammation: A roadmap to cancer immunoprevention. Mol Carcinog 2020;59:852-61. [PMID: 32333615 DOI: 10.1002/mc.23206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Hu C, Pang B, Lin G, Zhen Y, Yi H. Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells. Br J Cancer 2020;122:23-9. [PMID: 31819182 DOI: 10.1038/s41416-019-0644-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
17 Ashkenazi-Preiser H, Mikula I Jr, Baniyash M. The diverse roles of myeloid derived suppressor cells in mucosal immunity. Cell Immunol 2021;365:104361. [PMID: 33984533 DOI: 10.1016/j.cellimm.2021.104361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li S, Wang Z, Zhang G, Fu J, Zhang X. Interleukin-7 promotes lung-resident CD14+ monocytes activity in patients with lung squamous carcinoma. International Immunopharmacology 2019;67:202-10. [DOI: 10.1016/j.intimp.2018.12.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
19 Jayakumar A, Bothwell ALM. Functional Diversity of Myeloid-Derived Suppressor Cells: The Multitasking Hydra of Cancer. J Immunol 2019;203:1095-103. [PMID: 31427398 DOI: 10.4049/jimmunol.1900500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
20 Yang Z, Guo J, Weng L, Tang W, Jin S, Ma W. Myeloid-derived suppressor cells-new and exciting players in lung cancer. J Hematol Oncol 2020;13:10. [PMID: 32005273 DOI: 10.1186/s13045-020-0843-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 27.0] [Reference Citation Analysis]
21 Khadge S, Cole K, Talmadge JE. Myeloid derived suppressor cells and the release of micro-metastases from dormancy. Clin Exp Metastasis 2021;38:279-93. [PMID: 34014424 DOI: 10.1007/s10585-021-10098-8] [Reference Citation Analysis]
22 Xue VW, Chung JY, Córdoba CAG, Cheung AH, Kang W, Lam EW, Leung KT, To KF, Lan HY, Tang PM. Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity. Cancers (Basel) 2020;12:E3099. [PMID: 33114183 DOI: 10.3390/cancers12113099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
23 Yin Z, Li C, Wang J, Xue L. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy: Myeloid-derived suppressor cell. Int J Cancer 2019;144:933-46. [DOI: 10.1002/ijc.31744] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
24 Kinker GS, Vitiello GAF, Ferreira WAS, Chaves AS, Cordeiro de Lima VC, Medina TDS. B Cell Orchestration of Anti-tumor Immune Responses: A Matter of Cell Localization and Communication. Front Cell Dev Biol 2021;9:678127. [PMID: 34164398 DOI: 10.3389/fcell.2021.678127] [Reference Citation Analysis]
25 Wang Y, Jia A, Bi Y, Wang Y, Yang Q, Cao Y, Li Y, Liu G. Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy. Cancers (Basel) 2020;12:E2626. [PMID: 32942545 DOI: 10.3390/cancers12092626] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
26 van Wigcheren GF, Roelofs D, Figdor CG, Flórez-Grau G. Three distinct tolerogenic CD14+ myeloid cell types to actively manage autoimmune disease: Opportunities and challenges. J Autoimmun 2021;120:102645. [PMID: 33901801 DOI: 10.1016/j.jaut.2021.102645] [Reference Citation Analysis]
27 Yang Y, Li C, Liu T, Dai X, Bazhin AV. Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation. Front Immunol 2020;11:1371. [PMID: 32793192 DOI: 10.3389/fimmu.2020.01371] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 19.0] [Reference Citation Analysis]
28 Jin S, Yang Z, Hao X, Tang W, Ma W, Zong H. Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment. Biomark Res 2020;8:21. [PMID: 32551121 DOI: 10.1186/s40364-020-00201-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Li R, Dubinett SM. Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer. Transl Lung Cancer Res 2019;8:S331-3. [PMID: 32038908 DOI: 10.21037/tlcr.2019.04.10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. Front Immunol 2020;11:940. [PMID: 32499786 DOI: 10.3389/fimmu.2020.00940] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 42.0] [Reference Citation Analysis]
31 Magcwebeba T, Dorhoi A, du Plessis N. The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis. Front Immunol 2019;10:917. [PMID: 31114578 DOI: 10.3389/fimmu.2019.00917] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
32 Neri D, Carevic-Neri M, Brück J, Holstein J, Schäfer I, Solimani F, Handgretinger R, Hartl D, Ghoreschi K. Arginase 1+ IL-10+ polymorphonuclear myeloid-derived suppressor cells are elevated in patients with active pemphigus and correlate with an increased Th2/Th1 response. Exp Dermatol 2021;30:782-91. [PMID: 33528891 DOI: 10.1111/exd.14298] [Reference Citation Analysis]
33 Holloman BL, Nagarkatti M, Nagarkatti P. Epigenetic Regulation of Cannabinoid-Mediated Attenuation of Inflammation and Its Impact on the Use of Cannabinoids to Treat Autoimmune Diseases. Int J Mol Sci 2021;22:7302. [PMID: 34298921 DOI: 10.3390/ijms22147302] [Reference Citation Analysis]
34 Jaufmann J, Lelis FJN, Teschner AC, Fromm K, Rieber N, Hartl D, Beer-Hammer S. Human monocytic myeloid-derived suppressor cells impair B-cell phenotype and function in vitro. Eur J Immunol 2020;50:33-47. [PMID: 31557313 DOI: 10.1002/eji.201948240] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]